P Pollack

2.3k total citations · 1 hit paper
67 papers, 1.8k citations indexed

About

P Pollack is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, P Pollack has authored 67 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Genetics, 39 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in P Pollack's work include Inflammatory Bowel Disease (51 papers), Microscopic Colitis (35 papers) and Eosinophilic Esophagitis (10 papers). P Pollack is often cited by papers focused on Inflammatory Bowel Disease (51 papers), Microscopic Colitis (35 papers) and Eosinophilic Esophagitis (10 papers). P Pollack collaborates with scholars based in United States, France and Canada. P Pollack's co-authors include William J. Sandborn, Remo Panaccione, P. Rutgeerts, Jeffrey D. Kent, S. B. Hanauer, Donald MacIntosh, Douglas C. Wolf, Li Ju, Richard N. Fedorak and J F Colombel and has published in prestigious journals such as Blood, Gastroenterology and American Journal of Clinical Nutrition.

In The Last Decade

P Pollack

63 papers receiving 1.7k citations

Hit Papers

Adalimumab for maintenance treatment of Crohn’s disease: ... 2007 2026 2013 2019 2007 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial
    2007 798 citations William J. Sandborn, S. B. Hanauer et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Pollack United States 12 1.5k 1.2k 461 348 161 67 1.8k
Johannan F. Brandse Netherlands 14 878 0.6× 654 0.5× 199 0.4× 436 1.3× 47 0.3× 31 1.1k
Vincent Billioud France 11 1.0k 0.7× 789 0.6× 426 0.9× 227 0.7× 43 0.3× 14 1.3k
Johannes Stallhofer Germany 13 643 0.4× 369 0.3× 183 0.4× 577 1.7× 72 0.4× 28 1.2k
Shingo Kato Japan 18 375 0.3× 274 0.2× 330 0.7× 246 0.7× 39 0.2× 48 1.0k
B. B. Scott United Kingdom 12 375 0.3× 304 0.2× 168 0.4× 185 0.5× 81 0.5× 18 926
P. RUTGEERTS Belgium 14 471 0.3× 363 0.3× 253 0.5× 136 0.4× 44 0.3× 15 759
Andrew Ippoliti United States 22 540 0.4× 462 0.4× 685 1.5× 162 0.5× 28 0.2× 34 1.3k
Taku Kobayashi Japan 12 522 0.4× 332 0.3× 201 0.4× 361 1.0× 47 0.3× 41 903
J. Bart A. Crusius Netherlands 19 335 0.2× 437 0.4× 399 0.9× 343 1.0× 44 0.3× 36 1.1k
Filip J. Baert Belgium 12 461 0.3× 340 0.3× 184 0.4× 204 0.6× 53 0.3× 35 704

Countries citing papers authored by P Pollack

Since Specialization
Citations

This map shows the geographic impact of P Pollack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Pollack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Pollack more than expected).

Fields of papers citing papers by P Pollack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Pollack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Pollack. The network helps show where P Pollack may publish in the future.

Co-authorship network of co-authors of P Pollack

This figure shows the co-authorship network connecting the top 25 collaborators of P Pollack. A scholar is included among the top collaborators of P Pollack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Pollack. P Pollack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jeffries, Neal, Mary Link, Wynona Coles, et al.. (2025). Two Nonmyeloablative HLA-Matched Related Donor Allogeneic Hematopoietic Cell Transplantation Regimens in Patients with Severe Sickle Cell Disease. Transplantation and Cellular Therapy. 31(5). 305–318. 1 indexed citations
2.
3.
Pai, Rish K., Gert De Hertogh, Walter Reinisch, et al.. (2023). Impact of mirikizumab therapy on histologic measures of intestinal inflammation in a Phase 2 study of patients with moderately to severely active Crohn’s disease. Zeitschrift für Gastroenterologie. 61(5). e183–e184. 1 indexed citations
4.
Sandborn, William J., J F Colombel, Geert D’Haens, et al.. (2013). Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn’s disease. Current Medical Research and Opinion. 29(5). 483–493. 21 indexed citations
5.
Colombel, J F, P. J. Rutgeerts, William J. Sandborn, et al.. (2012). PWE-254 Impact of induction dosing on maintenance outcome with adalimumab in Crohn's disease. Gut. 61(Suppl 2). A401.1–A401. 3 indexed citations
6.
Schreiber, Stefanie, Walter Reinisch, J F Colombel, et al.. (2012). Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease. Journal of Crohn s and Colitis. 7(3). 213–221. 136 indexed citations
7.
Sandborn, W., J F Colombel, Kathleen G. Lomax, et al.. (2011). Achievement of early deep remission is associated with lower rates of weekly dosing for adalimumab-treated patients with crohn's disease: data from extend: Table 1. Gut. 60(Suppl 1). A136.2–A137. 10 indexed citations
8.
9.
Loftus, Edward V., J. Chao, Mei Yang, et al.. (2011). Markov model projection of remission status for early versus delayed step-up adalimumab use in moderate to severe crohn's disease. Gut. 60(Suppl 1). A137–A137. 1 indexed citations
10.
Colombel, J F, David A. Schwartz, William J. Sandborn, et al.. (2009). Adalimumab for the treatment of fistulas in patients with Crohn’s disease. Gut. 58(7). 940–948. 254 indexed citations
11.
Sandborn, William J., S. B. Hanauer, P. Rutgeerts, et al.. (2007). Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial. Gut. 56(9). 1232–1239. 798 indexed citations breakdown →
12.
Sandborn, William J., J F Colombel, P. Rutgeerts, et al.. (2006). Adalimumab Maintains Clinical Remission and Response in Patients with Active Crohnʼs Disease. The American Journal of Gastroenterology. 101. S458–S458. 1 indexed citations
13.
Sandborn, William J., P. Rutgeerts, Robert Enns, et al.. (2006). Adalimumab Rapidly Induces Clinical Remission and Response in Patients with Moderate to Severe Crohnʼs Disease Who Had Secondary Failure to Infliximab Therapy. The American Journal of Gastroenterology. 101. S448–S448. 19 indexed citations
14.
Schwartz, David A., Paul Rutgeerts, J F Colombel, et al.. (2006). Induction, Maintenance, and Sustainability of the Healing of Draining Fistulas in Patients with Crohnʼs Disease Treated with Adalimumab. The American Journal of Gastroenterology. 101. S458–S459. 3 indexed citations
15.
Sandborn, William J., S. Hanauer, Douglas C. Wolf, et al.. (2005). Maintenance of Remission over 1 Year in Patients with Active Crohnʼs Disease Treated with Adalimumab. The American Journal of Gastroenterology. 100. S311–S311. 11 indexed citations
16.
Sandborn, William J., Stephen B. Hanauer, Douglas C. Wolf, et al.. (2005). Remission and Clinical Response Induced and Maintained in Patients with Active Crohnʼs Disease Treated for 1-Year Open-Label with Adalimumab. The American Journal of Gastroenterology. 100. S316–S317. 4 indexed citations
17.
Hanauer, S. B., William J. Sandborn, P. Rutgeerts, et al.. (2005). Rapid Response to Human Anti-TNF Monoclonal Antibody Adalimumab in Patients with Moderate to Severely Active Crohnʼs Disease in the CLASSIC Study. The American Journal of Gastroenterology. 100. S313–S314.
18.
Pollack, P, et al.. (1992). Polyamines in human and rat milk and in infant formulas. American Journal of Clinical Nutrition. 56(2). 371–375. 92 indexed citations
19.
Rao, R. K., O. Koldovský, Murray Korc, et al.. (1990). Processing and transfer of epidermal growth factor in developing rat jejunum and ileum. Peptides. 11(6). 1093–1102. 20 indexed citations
20.
Pollack, P, et al.. (1989). Effects of enterally- and parenterally-administered bombesin on intestinal luminal tryptic activity and protein in the suckling rat. Cellular and Molecular Life Sciences. 45(4). 385–388. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johannan F. Brandse Breakdown of academic impact, for papers by Vincent Billioud Breakdown of academic impact, for papers by Johannes Stallhofer Breakdown of academic impact, for papers by Shingo Kato Breakdown of academic impact, for papers by B. B. Scott Breakdown of academic impact, for papers by P. RUTGEERTS Breakdown of academic impact, for papers by Andrew Ippoliti Breakdown of academic impact, for papers by Taku Kobayashi Breakdown of academic impact, for papers by J. Bart A. Crusius Breakdown of academic impact, for papers by Filip J. Baert
Rankless by CCL
2026